Additional factors likely exist that determine the inducibility of NIS expression in these cancer cells, as exemplified by the estrogen receptor status that determines the inducibility of NIS expression by all-trans retinoic acid in breast cancer cells [29]. The gene discussed is ESR1; the disease is breast carcinoma.